Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (3511)
All Articles published online
|
Aug 14, 2008 (publication date) through Apr 28, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Schimanski CC, Galle PR, Moehler M. Chemokine receptor CXCR4-prognostic factor for gastrointestinal tumors. World J Gastroenterol 2008; 14(30): 4721-4724 [PMID: 18720530 DOI: 10.3748/wjg.14.4721] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v14/i30/4721.htm |
| Number | Citing Articles |
| 1 |
Linhui Wang, Wei Chen, Li Gao, Qing Yang, Bing Liu, Zhenjie Wu, Yang Wang, Yinghao Sun. High expression of CXCR4, CXCR7 and SDF-1 predicts poor survival in renal cell carcinoma. World Journal of Surgical Oncology 2012; 10(1) doi: 10.1186/1477-7819-10-212
|
| 2 |
Kanjoormana A. Manu, Muthu K. Shanmugam, Lalitha Ramachandran, Feng Li, Chee Wai Fong, Alan Prem Kumar, Patrick Tan, Gautam Sethi. First Evidence That γ-Tocotrienol Inhibits the Growth of Human Gastric Cancer and Chemosensitizes It to Capecitabine in a Xenograft Mouse Model through the Modulation of NF-κB Pathway. Clinical Cancer Research 2012; 18(8): 2220 doi: 10.1158/1078-0432.CCR-11-2470
|
| 3 |
B. Weixler, F. Renetseder, I. Facile, N. Tosti, E. Cremonesi, A. Tampakis, T. Delko, S. Eppenberger-Castori, A. Tzankov, G. Iezzi, C. Kettelhack, S. D. Soysal, U. von Holzen, G. C. Spagnoli, L. Terracciano, L. Tornillo, Raoul A. Droeser, S. Däster. Phosphorylated CXCR4 expression has a positive prognostic impact in colorectal cancer. Cellular Oncology 2017; 40(6): 609 doi: 10.1007/s13402-017-0348-2
|
| 4 |
QingLing Yang, YongXing Ding, ChangJie Chen, Jie Tang, Ju Zhang, ZhiFeng Yang. Suppression of murine breast cancer metastasis by selective inhibition of CXCR4 by synthetic polypeptide derived from viral macrophage inflammatory protein II. Chinese Science Bulletin 2010; 55(20): 2152 doi: 10.1007/s11434-010-3262-9
|
| 5 |
Hongbo Li, Guoliang Yao, Bing Feng, Xueliang Lu, Yonggang Fan. Circ_0056618 and CXCR4 act as competing endogenous in gastric cancer by regulating miR‐206. Journal of Cellular Biochemistry 2018; 119(11): 9543 doi: 10.1002/jcb.27271
|
| 6 |
Jaroslaw Baran, Monika Baj-Krzyworzeka, Kazimierz Weglarczyk, Rafal Szatanek, Maria Zembala, Jakub Barbasz, Antoni Czupryna, Antoni Szczepanik, Marek Zembala. Circulating tumour-derived microvesicles in plasma of gastric cancer patients. Cancer Immunology, Immunotherapy 2010; 59(6): 841 doi: 10.1007/s00262-009-0808-2
|
| 7 |
HYO JIN LEE, SONG MEI HUANG, HA YON KIM, YOON SUK OH, JI YOUNG HWANG, ZHE LONG LIANG, JEONG KI MIN, HWAN JUNG YUN, JI YOUNG SUL, SAMYONG KIM, DEOG YEON JO, JIN MAN KIM. Evaluation of the combined expression of chemokine SDF-1α and its receptor CXCR4 as a prognostic marker for gastric cancer. Experimental and Therapeutic Medicine 2011; 2(3): 499 doi: 10.3892/etm.2011.228
|
| 8 |
Mohammad Amir Mishan, Naghmeh Ahmadiankia, Ahmad Reza Bahrami. CXCR4 and CCR7: Two eligible targets in targeted cancer therapy. Cell Biology International 2016; 40(9): 955 doi: 10.1002/cbin.10631
|
| 9 |
Roger H. Kim, Benjamin D. L. Li, Quyen D. Chu. The Role of Chemokine Receptor CXCR4 in the Biologic Behavior of Human Soft Tissue Sarcoma. Sarcoma 2011; 2011: 1 doi: 10.1155/2011/593708
|
| 10 |
Marta Łukaszewicz-Zając, Mariusz Gryko, Barbara Mroczko. The role of selected chemokines and their specific receptors in pancreatic cancer. The International Journal of Biological Markers 2018; 33(2): 141 doi: 10.1177/1724600817753094
|
| 11 |
Derek Zieker, Ingmar Königsrainer, Isabel Tritschler, Markus Löffler, Stefan Beckert, Frank Traub, Kay Nieselt, Sarah Bühler, Michael Weller, Jochen Gaedcke, Russell S. Taichman, Hinnak Northoff, Björn L.D.M. Brücher, Alfred Königsrainer. Phosphoglycerate kinase 1 a promoting enzyme for peritoneal dissemination in gastric cancer. International Journal of Cancer 2010; 126(6): 1513 doi: 10.1002/ijc.24835
|
| 12 |
Julio E. Valdivia-Silva, Janusz Franco-Barraza, Ana Luisa Esparza Silva, Gisela Du Pont, Gloria Soldevila, Isaura Meza, Eduardo A. García-Zepeda. Effect of pro-inflammatory cytokine stimulation on human breast cancer: Implications of chemokine receptor expression in cancer metastasis. Cancer Letters 2009; 283(2): 176 doi: 10.1016/j.canlet.2009.03.040
|
| 13 |
Vilma Oliveira Frick, Claudia Rubie, Pirus Ghadjar, Sabrina K. Faust, Mathias Wagner, Stefan Gräber, Martin K. Schilling. Changes in CXCL12/CXCR4-chemokine expression during onset of colorectal malignancies. Tumor Biology 2011; 32(1): 189 doi: 10.1007/s13277-010-0112-y
|
| 14 |
Luigina Graziosi, Andrea Mencarelli, Chiara Santorelli, Barbara Renga, Sabrina Cipriani, Emanuel Cavazzoni, Giuseppe Palladino, Stefan Laufer, Michael Burnet, Annibale Donini, Stefano Fiorucci. Mechanistic role of p38 MAPK in gastric cancer dissemination in a rodent model peritoneal metastasis. European Journal of Pharmacology 2012; 674(2-3): 143 doi: 10.1016/j.ejphar.2011.11.015
|
| 15 |
Kanjoormana A. Manu, Muthu K. Shanmugam, Lalitha Ramachandran, Feng Li, Kodappully Sivaraman Siveen, Arunachalam Chinnathambi, M.E. Zayed, Sulaiman Ali Alharbi, Frank Arfuso, Alan Prem Kumar, Kwang Seok Ahn, Gautam Sethi. Isorhamnetin augments the anti-tumor effect of capeciatbine through the negative regulation of NF-κB signaling cascade in gastric cancer. Cancer Letters 2015; 363(1): 28 doi: 10.1016/j.canlet.2015.03.033
|
| 16 |
Arezoo Rasti, Maryam Abolhasani, Leili Saeednejad Zanjani, Mojgan Asgari, Mitra Mehrazma, Zahra Madjd. Reduced expression of CXCR4, a novel renal cancer stem cell marker, is associated with high-grade renal cell carcinoma. Journal of Cancer Research and Clinical Oncology 2017; 143(1): 95 doi: 10.1007/s00432-016-2239-8
|
| 17 |
André Lollert, Theodor Junginger, Carl Christoph Schimanski, Stefan Biesterfeld, Ines Gockel, Christoph Düber, Katja Oberholzer. Rectal cancer: Dynamic contrast-enhanced MRI correlates with lymph node status and epidermal growth factor receptor expression. Journal of Magnetic Resonance Imaging 2014; 39(6): 1436 doi: 10.1002/jmri.24301
|
| 18 |
De-Min Ma, Dian-Xi Luo, Jie Zhang. SDF-1/CXCR7 axis regulates the proliferation, invasion, adhesion, and angiogenesis of gastric cancer cells. World Journal of Surgical Oncology 2016; 14(1) doi: 10.1186/s12957-016-1009-z
|
| 19 |
Zhi-Yu Song, Feng Wang, Shu-Xiang Cui, Xian-Jun Qu. Knockdown of CXCR4 Inhibits CXCL12-Induced Angiogenesis in HUVECs through Downregulation of the MAPK/ERK and PI3K/AKT and the Wnt/β-Catenin Pathways. Cancer Investigation 2018; 36(1): 10 doi: 10.1080/07357907.2017.1422512
|
| 20 |
Markus Moehler, Maike Delic, Katrin Goepfert, Daniela Aust, Heike I. Grabsch, Niels Halama, Bernd Heinrich, Catherine Julie, Florian Lordick, Manfred P. Lutz, Murielle Mauer, Maria Alsina Maqueda, Hansjoerg Schild, Carl C. Schimanski, Anna-Dorothea Wagner, Arnaud Roth, Michel Ducreux. Immunotherapy in gastrointestinal cancer: Recent results, current studies and future perspectives. European Journal of Cancer 2016; 59: 160 doi: 10.1016/j.ejca.2016.02.020
|
| 21 |
C Oelkrug, J M Ramage. Enhancement of T cell recruitment and infiltration into tumours. Clinical and Experimental Immunology 2014; 178(1): 1 doi: 10.1111/cei.12382
|
| 22 |
J. Ma, H. Su, B. Yu, T. Guo, Z. Gong, J. Qi, X. Zhao, J. Du. CXCL12 gene silencing down-regulates metastatic potential via blockage of MAPK/PI3K/AP-1 signaling pathway in colon cancer. Clinical and Translational Oncology 2018; 20(8): 1035 doi: 10.1007/s12094-017-1821-0
|
| 23 |
Annett Maderer, Frederic Fiteni, Erik Tanis, Murielle Mauer, Thomas Schmitt, Daniela E. Aust, Manfred P. Lutz, Felicitas Roelofson, Christiane Gog, Arndt Weinmann, Claus H. Koehne, Markus Moehler, Thomas Thomaidis. CXCR4 and hif-1α as prognostic molecular markers for stage 3 colon cancer patients: post hoc analysis of the randomized, multicenter phase 3 PETACC-2 trial dataset. Acta Oncologica 2021; 60(11): 1543 doi: 10.1080/0284186X.2021.1959057
|
| 24 |
Chunhui Lu, Shiwen Chen, Feng Xu, Yiwen Chen, Qing Zhang, Yong Li. Expressions of CCR7 and CXCR4 Are Associated with Differentiation in Gastrointestinal Cancer. Journal of Cancer Therapy 2013; 4(01): 49 doi: 10.4236/jct.2013.41A007
|
| 25 |
Susumu Saigusa, Yuji Toiyama, Koji Tanaka, Takeshi Yokoe, Yoshinaga Okugawa, Aya Kawamoto, Hiromi Yasuda, Yasuhiro Inoue, Chikao Miki, Masato Kusunoki. Stromal CXCR4 and CXCL12 Expression is Associated with Distant Recurrence and Poor Prognosis in Rectal Cancer After Chemoradiotherapy. Annals of Surgical Oncology 2010; 17(8): 2051 doi: 10.1245/s10434-010-0970-y
|
| 26 |
Philipp Linde, Christian Baues, Simone Wegen, Maike Trommer, Alexander Quaas, Johannes Rosenbrock, Eren Celik, Simone Marnitz, Christiane J. Bruns, Thomas Fischer, Klaus Schomaecker, Hans-Juergen Wester, Alexander Drzezga, Lutz van Heek, Carsten Kobe. Pentixafor PET/CT for imaging of chemokine receptor 4 expression in esophageal cancer – a first clinical approach. Cancer Imaging 2021; 21(1) doi: 10.1186/s40644-021-00391-w
|
| 27 |
Janoš Terzić, Sergei Grivennikov, Eliad Karin, Michael Karin. Inflammation and Colon Cancer. Gastroenterology 2010; 138(6): 2101 doi: 10.1053/j.gastro.2010.01.058
|
| 28 |
Ala Litman-Zawadzka, Marta Łukaszewicz-Zając, Barbara Mroczko. Novel potential biomarkers for pancreatic cancer – A systematic review. Advances in Medical Sciences 2019; 64(2): 252 doi: 10.1016/j.advms.2019.02.004
|
| 29 |
Florian Gebauer, Michael Tachezy, Katharina Effenberger, Katharina von Loga, Hilke Zander, Alexander Marx, Jussuf T. Kaifi, Guido Sauter, Jakob R Izbicki, Maximilian Bockhorn. Prognostic impact of CXCR4 and CXCR7 expression in pancreatic adenocarcinoma. Journal of Surgical Oncology 2011; 104(2): 140 doi: 10.1002/jso.21957
|
| 30 |
Larissa Belov, Jerry Zhou, Richard I. Christopherson. Cell Surface Markers in Colorectal Cancer Prognosis. International Journal of Molecular Sciences 2010; 12(1): 78 doi: 10.3390/ijms12010078
|
| 31 |
Sébastien Albert, Maria Eugenia Riveiro, Caroline Halimi, Muriel Hourseau, Anne Couvelard, Maria Serova, Béatrix Barry, Eric Raymond, Sandrine Faivre. Focus on the role of the CXCL12/CXCR4 chemokine axis in head and neck squamous cell carcinoma. Head & Neck 2013; 35(12): 1819 doi: 10.1002/hed.23217
|
| 32 |
VINCENT LUCANSKY, MONIKA KRMENCIKOVA-FLIEGL, LIBOR STANEK, VLADIMIR VONKA. Administration of a plasmid that expresses SDF-1α affects the oncogenic potential of mouse bcr-abl-transformed cells. Molecular Medicine Reports 2014; 10(4): 2116 doi: 10.3892/mmr.2014.2425
|
| 33 |
Tong Li, Hui Li, Yucheng Wang, Chansonette Harvard, Jia‐Li Tan, Alfred Au, Zhidong Xu, David M Jablons, Liang You. The expression of CXCR4, CXCL12 and CXCR7 in malignant pleural mesothelioma. The Journal of Pathology 2011; 223(4): 519 doi: 10.1002/path.2829
|
| 34 |
Elda Righi, Satoshi Kashiwagi, Jianping Yuan, Michael Santosuosso, Pierre Leblanc, Rachel Ingraham, Benjamin Forbes, Beth Edelblute, Brian Collette, Deyin Xing, Magdalena Kowalski, Maria Cristina Mingari, Fabrizio Vianello, Michael Birrer, Sandra Orsulic, Glenn Dranoff, Mark C. Poznansky. CXCL12/CXCR4 Blockade Induces Multimodal Antitumor Effects That Prolong Survival in an Immunocompetent Mouse Model of Ovarian Cancer. Cancer Research 2011; 71(16): 5522 doi: 10.1158/0008-5472.CAN-10-3143
|
| 35 |
A Popple, L G Durrant, I Spendlove, P Rolland, I V Scott, S Deen, J M Ramage. The chemokine, CXCL12, is an independent predictor of poor survival in ovarian cancer. British Journal of Cancer 2012; 106(7): 1306 doi: 10.1038/bjc.2012.49
|
| 36 |
Zhi-Yu Song, Zu-Hua Gao, Jia-Hui Chu, Xiu-Zhen Han, Xian-Jun Qu. Downregulation of the CXCR4/CXCL12 axis blocks the activation of the Wnt/β-catenin pathway in human colon cancer cells. Biomedicine & Pharmacotherapy 2015; 71: 46 doi: 10.1016/j.biopha.2015.01.020
|
| 37 |
Jacob J. Briedé, Joost M. H. van Delft, Theo M. C. M. de Kok, Marcel H. M. van Herwijnen, Lou M. Maas, Ralph W. H. Gottschalk, Jos C. S. Kleinjans. Global Gene Expression Analysis Reveals Differences in Cellular Responses to Hydroxyl- and Superoxide Anion Radical–Induced Oxidative Stress in Caco-2 Cells. Toxicological Sciences 2010; 114(2): 193 doi: 10.1093/toxsci/kfp309
|
| 38 |
Zhi-Yu Song, Zu-Hua Gao, Xian-Jun Qu. A review of CXCR4/CXCL12 axis in colorectal cancer. Biomedicine & Aging Pathology 2014; 4(3): 285 doi: 10.1016/j.biomag.2014.06.001
|
| 39 |
Abdullah Moridikia, Hamed Mirzaei, Amirhossein Sahebkar, Jafar Salimian. MicroRNAs: Potential candidates for diagnosis and treatment of colorectal cancer. Journal of Cellular Physiology 2018; 233(2): 901 doi: 10.1002/jcp.25801
|
| 40 |
Fabio Walther, Jana Ladina Berther, Alexandros Lalos, Michaela Ramser, Simone Eichelberger, Robert Mechera, Savas Soysal, Simone Muenst, Alberto Posabella, Uwe Güth, Sylvia Stadlmann, Luigi Terracciano, Raoul A. Droeser, Jasmin Zeindler, Gad Singer. High ratio of pCXCR4/CXCR4 tumor infiltrating immune cells in primary high grade ovarian cancer is indicative for response to chemotherapy. BMC Cancer 2022; 22(1) doi: 10.1186/s12885-022-09374-x
|